AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Total Non-Current Liabilities | ₹131 Cr | ₹85 Cr | ₹73 Cr | - |
What is the latest Total Non-Current Liabilities ratio of AARTI PHARMALABS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹131 Cr |
Mar2023 | ₹85 Cr |
Mar2022 | ₹73 Cr |
Mar2021 | - |
How is Total Non-Current Liabilities of AARTI PHARMALABS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹131 Cr | 53.89 | |
Mar2023 | ₹85 Cr | 16.71 | |
Mar2022 | ₹73 Cr | 0 | |
Mar2021 | - | - |
Compare Total Non-Current Liabilities of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹6,719.8 Cr | 9.1% | 13.3% | 45.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -2.8% | -3.6% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.5% | 1.5% | 59.1% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | -1.5% | 0.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.6% | -9.2% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,002.4 Cr | -7.4% | -5.1% | 9.9% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 9.1% |
13.3% |
45.2% |
SENSEX | -2.7% |
-0.4% |
6.4% |
You may also like the below Video Courses